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Assessment of procalcitonin and other inflammatory markers
in peritoneal dialysis-related peritonitis*
Reyhan ÖZTÜRK1, Gül R. YILMAZ1, Cemal BULUT1, Hülya PARPUCU2, Sami KINIKLI1,
Murat DURANAY2, Ali Pekcan DEMİRÖZ1

Aim: It is demonstrated that in end-stage renal failure without an infectious pathology conventional laboratory
parameters such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) or other acute-phase proteins
increase non-specifically. We aimed to evaluate procalcitonin (PCT) and other inflammatory markers such as C-reactive
protein (CRP) and erythrocyte sedimentation rate (ESR) in patients with continuous ambulatory peritoneal dialysis
(CAPD)-related peritonitis.
Materials and methods: A case-control study was conducted in a 600-bed tertiary hospital. Fifty patients with CAPDrelated peritonitis constituting the study group and 50 CAPD patients without infection as the control group were
included in the study between February 2006 and July 2006. Baseline serum WBC count, PCT, ESR, and CRP levels were
determined in all patients.
Results: Fifty-six peritonitis episodes were detected in 50 patients. The mean ESR and CRP levels were significantly
higher in the study group (P < 0.001). PCT levels were >0.5 ng/mL in 21 of the 50 patients (42%) in the study group and
8 of the 50 patients (16%) in the control group. The positive predictive value was 100% for CRP levels higher than 5
mg/dL and PCT levels higher than 2 ng/mL. The sensitivities were calculated as 40% and 14% by the same cut-off levels
for CRP and PCT, respectively.
Conclusion: Serum CRP level is a significant and valuable parameter for detecting inflammation, and determining a
new cut-off point for CRP will increase its usefulness in patients with CAPD-related peritonitis. The sensitivity and
specificity of PCT were not superior to CRP in peritoneal dialysis-related peritonitis.
Key words: Procalcitonin, C-reactive protein, peritonitis, inflammation markers

Peritoneal diyalizle ilişkili peritonitte prokalsitonin ve
diğer inflamatuar parametrelerin değerlendirilmesi
Amaç: Kronik böbrek yetmezliği (KBY) tanılı hastalarda herhangi bir infeksiyöz patoloji olmadan da eritrosit
sedimentasyon hızı, C-reaktif protein ve diğer akut faz proteinleri gibi sık kullanılan inflamatuar parametrelerde artış
olduğu bildirilmiştir. Bu çalışmada peritoneal diyaliz ilişkili peritonit tanılı hastalarda prokalsitonin ile C-reaktif protein
(CRP) ve eritrosit sedimentasyon hızı (ESR) gibi diğer inflamatuar parametrelerin durumu incelendi.
Yöntem ve gereç: Çalışma 600 yataklı bir eğitim ve araştırma hastanesinde yapıldı. Şubat 2006 ile Temmuz 2006 tarihleri
arasında süreli ayaktan periton diyalizi ile ilişkili peritonit tanısı alan 50 hasta çalışma grubu, sürekli ayaktan periton
diyalizi uygulanan ve herhangi bir infeksiyon belirti ve bulgusu olmayan 50 olgu kontrol grubu olarak alındı. Tüm
hastalarda serum beyaz küre sayısı, prokalsitonin, ESR ve CRP düzeyleri çalışıldı.
Bulgular: Çalışma grubundaki 50 hastada 56 peritonit atağı tespit edildi. Çalışma grubunda yer alan hastaların ortalama
ESR ve CRP düzeyleri kontrol grubuna göre yüksek bulundu (P < 0,001). PKT düzeyi çalışma grubundaki 50 hastanın
21’inde (% 42), kontrol grubundaki 50 hastanın 8’inde (% 16) 0,5 ng/mL’nin üzerinde bulundu. Peritonitli hastalarda 5
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mg/dL’den daha yüksek CRP ve 2 ng/mL’den daha yüksek PKT düzeylerinin her ikisi için pozitif prediktif değerler %
100 olarak saptandı. CRP ve PKT’nin aynı cut-off değerleri için duyarlılıkları % 40 ve % 14 olarak bulundu.
Sonuç: CRP inflamasyonun tespitinde önemli ve yararlı bir parametredir. Peritoneal diyaliz uygulanan hastalarda CRP
için 5 mg/dL değerinin cut-off olarak alınması, sürekli ayaktan periton diyalizine bağlı peritonitte bu parametrenin
yararına katkı sağlayacaktır. Periton diyalizi hastalarında prokalsitoninin sensivite ve spesifitesinin CRP’ye bir üstünlüğü
yoktur.
Anahtar sözcükler: Prokalsitonin, C-reaktif protein, peritonit, inflamasyon belirleyicileri

Introduction
It is demonstrated that in end-stage renal failure
without an infectious pathology conventional
laboratory parameters such as erythrocyte
sedimentation rate (ESR) and C-reactive protein
(CRP) or other acute-phase proteins increase nonspecifically (1-3). Procalcitonin (PCT), a polypeptide
of 116 aminoacids (MW 13 kDa), is the precursor of
calcitonin (4,5). It has been recently investigated as a
new alternative inflammatory parameter to
distinguish infections and other inflammatory events
in a number of studies. High serum levels of PCT have
been demonstrated in sepsis, bacterial, and fungal
infections (5,6). The literature reveals only a few
studies evaluating PCT in peritoneal dialysis (PD) and
PD-related peritonitis (7-10).
The present study aimed to determine the
diagnostic value of PCT and other conventional
inflammatory markers and whether PCT is related to
CRP, ESR, and white blood cell (WBC) count in
patients with continuous ambulatory peritoneal
dialysis (CAPD)-related peritonitis.
Materials and methods
Setting and Design
A case-control study was conducted in the
Infectious Diseases and Clinical Microbiology
Department and PD Unit of Nephrology Department
of the 600-bed Ankara Training and Research
Hospital between February 2006 and July 2006.
Patients
Fifty patients with CAPD-related peritonitis
treated in the Infectious Diseases and Clinical
Microbiology Clinic were included in the study as the
study group. During the study period 50 consecutive
patients who were followed-up in the PD Unit of the
200

Nephrology Department were included in the study
as the control group. The exclusion criteria consisted
of history of any infection in previous 4 weeks,
immunosuppressive therapy, steroid use, and clinical,
radiological, or microbiological evidence of any
infection.
All patients had a standard Tenckhoff catheter and
double bag connecting system. Peritoneal dialysis
fluid was lactate-based dialysate with glucose
concentrations ranging from 1.5 to 4.25 g/L. The
patients performed 4 exchanges per day with 2 L.
Diagnosis of Peritonitis
Peritonitis was defined as the development of
cloudy peritoneal dialysis with or without abdominal
pain, fever, vomiting, or nausea and WBC count being
3
higher than 100 WBC/mm with more than 50%
polymorphonuclear leukocytes, the presence of
microorganism in Gram staining and/or positive
culture (11).
Clinical and Microbiological Data
Age, gender, and duration of CAPD were recorded
in both groups. The symptoms, physical examination
findings, WBC counts, microscopy and culture results
of peritoneal dialysates, and antibiotic sensitivity
results of isolated microorganisms were recorded in
patients with peritonitis. After peritoneal dialysate
was obtained for microbiological investigation,
intraperitoneal cefazolin and gentamicin were
administered empirically. Treatment was modified
according to the culture results. The patients were
followed-up until the end of treatment.
Investigated Laboratory Parameters
ESR
The Westerngren method was used for ESR
measurement and levels greater than 15 mm/h was
regarded as high.
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CRP
CRP was measured by the nephelometric assay
(Beckman Coulter IMMAGE, Berkman, Marburg,
Germany). The normal range was defined as 0.0-0.8
mg/dL.
PCT
PCT was measured using the Brahms PCT-Q
rapid card test (Brahms, Henningsdorf, Germany).
The results were given in 4 groups as follows: (1) lower
than 0.5 ng/mL, (2) between 0.5 and 2 ng/mL, (3)
between 2 and 10 ng/mL, and (4) higher than 10
mg/dL.
In the study group, CRP, ESR, PCT, and other
laboratory parameters were assessed on the first day of
peritonitis and the 14th day of treatment. CRP levels
were also determined on the 2nd day of treatment.
Statistical analysis
All statistical analyses were performed using SPSS
for Windows 13.0. All data were expressed as mean ±
SD for normal distribution and median or range
values were used for skewed data. Chi-square or
Fisher’s exact test was used in univariate analysis.
Spearman’s correlation coefficient was used for
correlations.
The study was conducted in accordance with the
ethical approval regulations of the hospital.
Results
Fifty patients (35 male, 15 female) with peritonitis
were included in the study. During the study period,

56 peritonitis episodes were detected in 50 patients.
Fifty CAPD patients without peritonitis were included
in the study as the control group. Mean age of the
patients in the study group was 49.0 ± 16.9 years and
mean age of the patients of the control group was 44.8
± 14.4 years. The demographic characteristics were
not significantly different between the study and
control groups (Table 1). The causative
microorganisms are shown in Table 2. During followup, 2 patients died and in 3 of the 6 patients who
developed a second peritonitis episode the treatment
was switched to hemodialysis.
ESR
ESR levels were elevated in 47 of the 50 patients in
the study group (94%) and 44 of the 50 patients in the
control group (92%). ESR values ranged between 6
and 132 mm/h in the study group and between 6 and
120 mm/h in the control group. The mean ESR value
was significantly higher in patients with peritonitis,
when compared with the control group (P < 0.01)
(Table 1). On the 1st day of peritonitis and on the 14th
day of peritonitis, mean ESR values were 61.5 ± 29.1
and 57.6 ± 27.1 mm/h, respectively. The change in
ESR values was statistically significant (P = 0.013).
CRP
CRP levels were elevated in 88% of the study group
(44/50) and 26% of the control group (13/50). The
highest CRP levels detected were 41.5 mg/dL in the
study group and 4.9 mg/dL in the control group. The
median CRP level was significantly higher in the
patient group, when compared with the control group
(P < 0.001) (Table 1). Mean CRP level decreased from

Table 1. Some demographic characteristics and laboratory parameters of the study and control groups on the day of admission.
Demographic characteristic/
laboratory parameter (n)
Age
Gender (F/M)
Duration of renal failure (median, months)
Duration of CAPD (months)
Serum WBC 103/mm3
ESR mm/h
CRP mg/dL*

Study group
n (%)

Control group
n (%)

P

49.0 ± 16.9
15 (30)/ 35 (70)
24 (3-180)
20 ± 18
10.1 (3.8-24.5)
61.5 ± 29.1
3.1 (0.27-41.5)

44.8±14.4
25 (50)/ 25 (50)
33 (3-240)
22 ± 17
9.2 (4.7-23)
46.1 ± 25.3
0.51 (0.1-4.9)

0.188
0.06
0.196
0.632
0.306
< 0.01
< 0.001

*median
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Table 2.

The causative microorganisms in the peritonitis
episode.

Microorganism

Number

%

CNS1
S. aureus
E. coli
Klebsiella spp.
Pseudomanas spp.
Enterococcus spp.
Streptococcus spp.
C. albicans
Difteroid spp.
Culture negative

23
4
4
3
3
3
1
1
1
15

39.6
6.9
6.9
5.2
5.2
5.2
1.7
1.7
1.7
25.9

Total

58

100.0

1

CNS: coagulase-negative staphylococcus

7.0 mg/dL on the 1st day of peritonitis to 5.7 mg/dL
on the 2nd day of treatment. The change in CRP levels
during treatment was statistically significant (P <
0.05). The mean CRP level decreased to 2.6 mg/dL on
the 14th day of therapy (P < 0.01). CRP levels of
patients who had normal CRP levels on the 1st day of
peritonitis did not increase during follow-up. These
patients were older, with lower ESR and normal PCT
levels.
PCT
Plasma PCT levels were elevated in 42% of patients
in the study group (21/50) and 16% of patients in the
control group (8/50). PCT levels of 8 patients in the
control group were lower than 2 ng/mL. When the
cut-off level was taken as 0.5 ng/mL, PCT levels were
elevated in 22 of 56 (39.3%) episodes: ≥0.5 - <2
ng/mL in 14 episodes, ≥2 - <10 ng/mL in 4 episodes,
and ≥10 ng/mL in 4 episodes. PCT levels were found

as <0.5 ng/mL in 13 episodes (60%) and as ≥0.5 -<2
ng/mL in 9 episodes on the 14th day of therapy (Table
3).
To evaluate the diagnostic values of CRP, ESR, and
WBC, ROC plot analysis was performed (Figure). In
the plots for ESR and CRP, the area under the curve
was significantly associated with a diagnosis of
peritonitis (Table 4).
The predictive values of inflammatory markers in
the diagnosis of peritonitis were calculated according
to the following criteria: 11.000/mm3 for WBC, 15
mm/h for ESR, 0.8 mg/dL for CRP, and >2 ng/mL and
>0.5 ng/mL for PCT. Cut-off values of WBC, ESR, and
CRP were also calculated by ROC curves prepared for
diagnosing peritonitis. These values were calculated
as 11.800/mm3 for WBC, 72 mm/h for ESR, and
>4.915 mg/dL for CRP. The predictive values of
inflammatory markers in the diagnosis of peritonitis
were calculated by these values. The positive
predictive value was found as 100% for both CRP,
being higher than 5 mg/dL and PCT being higher
than 2 ng/mL. The sensitivities were calculated as 40%
and 14% by the same cut-off levels for CRP and PCT,
respectively (Table 5).
The evaluation of the correlation between
inflammatory parameters revealed that PCT was
positively correlated with CRP, peripheral WBC
count, and peritoneal fluid WBC count (P < 0.05).
CRP was positively correlated with ESR (r = 0.200, P
< 0.05) and peripheral WBC count (r = 0.293, P <
0.01) in addition to PCT (r = 0.4472, P < 0.001).
Discussion
Peritonitis is one of the major complications of
CAPD and it increases the morbidity and mortality

Table 3. PCT levels of patients in both groups.

PCT

Study group on the 14th
day of treatment

Control group

Study group day 0

<0.5 ng/mL
≥0.5 and <2 ng/mL
≥2 and <10 ng/mL
≥10 ng/mL

42
8

34
14
4
4

47
9

Total

50

56

56
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Table 4. Area under the curve for WBC, ESR, and CRP.
1.0

Variable

95% CI

P

0.526
0.662
0.887

0.414-0.638
0.558-0.766
0.827-0.948

0.644
< 0.01
< 0.001

WBC
ESR
CRP

0.8

Sensitivity

AUROC

0.6

Table 5. Sensitivity, specificity, positive and negative predictive
values for WBC, ESR, CRP, and PCT.

0.4
Source of the Curve
0.2

0.0
0.0

Variable (cut-off)

sWBC
sESR
sCRP
Reference Line
0.2

0.4
0.6
0.8
1 - Specificity
Diagonal segments are produced by ties.

1.0

Figure. ROC curve.

rates in this patient group (12-15). Multiple peritonitis
episodes can put an end to the CAPD program and
more dependent treatment modalities like
hemodialysis may be required (16-18). Thus, early
diagnosis and treatment of peritonitis episodes are of
critical importance. Conventional laboratory markers
like white cell count, ESR, and CRP are usually
affected by the underlying disease, uremia, and renal
replacement therapy (3,19). In patients with end stage
renal disease (ESRD), an ideal biochemical marker,
which is going to be used for the early diagnosis of
bacterial infection, should discriminate infection
from other inflammatory events, should give some
idea about the severity of infection, and should not be
affected by the severity of renal failure and renal
replacement treatments (20). This is why the value of
procalcitonin (PCT), which was first identified by
Assicot in 1993, is still under investigation in terms of
diagnosing the infections seen in patients with ESRD
(5). Most of these studies are performed on patients
undergoing hemodialysis (HD) treatment (8,21,22).
The literature reveals that in patients undergoing
peritoneal dialysis (PD) and diagnosed with CAPDrelated peritonitis only a few studies have investigated
PCT (7-10).

WBC > 11800*
ESR >15
ESR > 72*
CRP >0.8
CRP > 5*
PCT > 2
PCT > 0.5

Sensitivity

Specificity

PPV

NPV

28
94
40
90
40
14
42

90
8
90
11.9
100
100
84

73.7
50.5
80
77.6
100
100
72

55.6
57.1
60
74
62.5
53.8
59.2

*Cut-off values according to the ROC curves.

As seen in HD patients, PD patients can also have
high procalcitonin levels without an associating
infectious pathology. In relevant studies, mean PCT
levels of PD patients are reported to be higher than
those in both healthy controls and patients not
undergoing PD despite renal failure (7,10,23).
However, only one of these studies reported the
proportion of patients with high PCT levels, and other
authors preferred to present their results in the form
of mean PCT comparisons (7). In the abovementioned study performed by Guz et al., 5.8% of PD
patients had PCT levels higher than 0.5 ng/mL, being
as high as 1.6 times the upper normal limit (7). This
rate is higher in the present study, in which 16% of
patients in the control group had PCT levels in the
0.5-2 ng/mL interval. In the study by Guz et al., it was
reported that 44 patients out of 51 were undergoing
CAPD treatment and other patients were undergoing
automatized PD treatment, but the group in which
these 3 patients with high PCT levels were included
was not specified (7). In the present study all patients
were undergoing CAPD treatment. In patients
undergoing automatized PD and CAPD therapies, as
data in the literature about baseline PCT levels are
insufficient, we think that further investigations on
203
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this subject are required. In the present study, the kit
used for PCT measurements (Brahms PCT-Q rapid
card test, Brahms, Henningsdorf, Germany) is
different from the kit used in the study by Guz et al.
(LUMItest PCT kit, B.R.A.H.M.S. Diagnostica,
Germany) and the effect of this difference could be
clarified with a study using different kits performed
in the same patient group. One study found that PCT
levels of PD patients were significantly high, when
compared with HD patients and ESRD patients who
were not undergoing renal replacement therapy, and
thus it was suggested that PCT can be used in patients
with renal failure but with exception of patients on
CAPD (23). The reason for the increase in PCT levels
of PD patients without signs of infection is explained
by some hypotheses. These include the stimulation of
PCT release depending on an inflammatory activity
triggered by uremia or dialysis itself; renal failure
leading to a decrease in PCT excretion and retention;
and intra-abdominal fluid volume and/or dialysis
catheter, which can lead to chronic endotoxemia
(10,23,24). In the literature, various results about the
decrease in PCT excretion with regard to renal failure
have been reported (20,23). In a study comparing
PCT levels of patients who were at different stages of
renal failure, there was no significant difference
between patient groups, and the slight increase in
PCT levels was suggested to be related to uremia and
extracorporeal treatment (20). Another study stated
that a majority of PCT was excreted from the liver
(23).
The cut-off level of PCT in patients without
uremia was 0.5 ng/mL, while a level of 1.5 ng/mL was
suggested for patients undergoing programmed HD
in a regular fashion (8,21,22). However, in the study
by Guz et al., as only 5.8% of PD patients had PCT
levels higher than 0.5 ng/mL, this value was suggested
as a cut-off (7). As mentioned earlier, in the present
study, 16% of patients with PCT levels higher than 0.5
ng/mL did not have any sign of infection.
In the present study 42% of patients diagnosed
with peritonitis and 39.3% of peritonitis episodes had
PCT levels higher than 0.5 ng/mL. In the study by Guz
et al., 62% of peritonitis episodes had PCT levels
higher than 0.5 ng/mL (7). The rate in the present
study being this low can arise from different kits used
or be related to different intrinsic patient factors.
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In the present study, 58% of patients diagnosed
with peritonitis had normal PCT levels. It is known
that PCT levels rise in severe infections and sepsis,
while staying under the 0.5 ng/mL limit in viral
infections, local infections, allergic states, and
autoimmune diseases (5,6,25,26). We think that the
reason why PCT levels did not increase in all episodes
is that the majority of peritonitis episodes remained
localized infections.
It is known that in PD patients about 90% have
high ESR and 25%-60% have high CRP levels
(7,27,28). In ESRD patients, most factors like anemia,
which are supposed to affect ESR, have no influence
on CRP values; nevertheless, the increase in CRP
levels can be under the influence of inflammation and
tissue damage, as well as infection (29). In the present
study, when the parameters of subjects in the control
group were evaluated, it was revealed that 92% had
high ESR and 26% had high CRP levels.
In the present study, high CRP levels (for the kit
used, the upper limit of normal range is 0.8 mg/dL)
had a sensitivity of 90% and a specificity of 11.9%, the
latter being especially low, when compared with the
specificity of PCT levels being higher than the 0.5
ng/mL limit (84%). ROC curves were prepared for
calculating cut-off values and, according to them, in
diagnosing peritonitis the sensitivity of CRP levels
higher than 5 mg/dL and PCT levels higher than 0.5
ng/mL were more or less similar (40% versus 42%),
while the specificity of CRP was higher than PCT
(100% versus 84%). On the other hand, while PCT
levels higher than the 2 ng/mL limit had a specificity
of 100%, this threshold could only determine 14% of
cases of peritonitis. We think that, although PCT
levels > 0.5 ng/mL have a lower specificity, taking
them into consideration would be more appropriate
because of sensitivity. When the cut-off value was
reestablished as 5 mg/dL for CRP according to the
ROC curve, the sensitivity and specificity of PCT were
not superior to those of CRP. However, in our
comparisons, the cut-off value of the CRP kit was
taken as 0.8 mg/dL according to its manufacturer and
the threshold for ESR was taken as 15 mm/h, thus
demonstrating that PCT, despite its low sensitivity,
had quite a high specificity. Similar results were
reported in the study by Guz et al. (7). In the present
study, the specificity of cut-off levels calculated
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according to the ROC curve were higher in terms of
diagnosing peritonitis, when compared with the cutoff values formerly used for the same conventional
inflammatory markers. It was emphasized that PCT
is more valuable than CRP in the diagnosis of
bacterial infection, while the latter is still an important
inflammatory parameter in clinical practice (30). As
increased CRP can be related to non-infectious
reasons, we advocate that in the practical approach
the clinic signs of the patient being taken into
consideration together with CRP and PCT would be
more appropriate. A limitation of the present study
was PCT measurements not being studied by the
quantitative method. Thus, during calculations of
PCT sensitivity and specificity, only > 0.5 and >2
ng/mL values were used as cut-off limits.
It was also suggested that, as half-life of CRP is
longer, PCT could be more valuable in reflecting the
treatment response, and thus should be followed-up

on a daily basis (30-33). In the present study, levels of
all parameters (ESR, CRP, and PCT) decreased
significantly at the end of treatment. However, as PCT
was not studied on a daily basis, no information could
be provided with regard to its more rapid decrease
when compared with CRP and ESR.
The evaluation of correlations between
inflammatory parameters revealed that PCT was
positively correlated with CRP, peripheral WBC
count, and peritoneal fluid WBC count.
The present study investigated the diagnostic and
prognostic value of an encouraging inflammatory
parameter, namely PCT, in patients diagnosed with
CAPD-related peritonitis. When the cut-off value of
CRP was reestablished by ROC curves, it was
observed that the sensitivity and specificity of PCT
were not superior to CRP in terms of diagnosing
peritonitis. However, we think that confirmation of
this finding with further studies is necessary.
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